Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Wood

Showing results (251-260 of 369) with videos related to

Pageof 37
Sort By:
AIDS (London, England)|March 13, 2009
Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar puncturesTihana Bicanic, Annemarie E Brouwer, Graeme Meintjes, et al.
Antiviral Therapy|April 11, 2023
Abacavir safety and effectiveness in young infants with HIV in South African observational cohortsReneé de Waal, Helena Rabie, Karl-Günter Technau, et al.
PLOS Global Public Health|July 15, 2025
Within-country heterogeneity in patterns of social contact relevant for tuberculosis infection transmission, prevention, and careKate E LeGrand, Anita Edwards, Mbali Mohlamonyane, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 22, 2012
Rates and predictors of failure of first-line antiretroviral therapy and switch to second-line ART in South AfricaMatthew P Fox, Gilles Van Cutsem, Janet Giddy, et al.
AIDS (London, England)|May 11, 2013
Zidovudine impairs immunological recovery on first-line antiretroviral therapy: collaborative analysis of cohort studies in southern AfricaGilles Wandeler, Thomas Gsponer, Lloyd Mulenga, et al.
Annals of Internal Medicine|July 22, 2009
When to start antiretroviral therapy in resource-limited settingsRochelle P Walensky, Lindsey L Wolf, Robin Wood, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 5, 2021
Factors Associated With and Characteristic of HIV/Tuberculosis Co-Infection: A Retrospective Analysis of SECOND-LINE Clinical Trial ParticipantsRebecca T Henry, Awachana Jiamsakul, Matthew Law, et al.
AIDS (London, England)|July 1, 2014
Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in AfricaMaya L Petersen, Linh Tran, Elvin H Geng, et al.
The Pediatric Infectious Disease Journal|January 1, 2014
Virologic response in children treated with abacavir-compared with stavudine-based antiretroviral treatment: a South African multi-cohort analysisKarl-Günter Technau, Michael Schomaker, Louise Kuhn, et al.
BMJ Open|August 28, 2020
Novel approach to estimate tuberculosis transmission in primary care clinics in sub-Saharan Africa: protocol of a prospective studyKathrin Zürcher, Carl Morrow, Julien Riou, et al.
Pageof 37

Showing results (251-260 of 369) with videos related to

Sort By:
Pageof 37
AIDS (London, England)|March 13, 2009
Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar puncturesTihana Bicanic, Annemarie E Brouwer, Graeme Meintjes, et al.
Antiviral Therapy|April 11, 2023
Abacavir safety and effectiveness in young infants with HIV in South African observational cohortsReneé de Waal, Helena Rabie, Karl-Günter Technau, et al.
PLOS Global Public Health|July 15, 2025
Within-country heterogeneity in patterns of social contact relevant for tuberculosis infection transmission, prevention, and careKate E LeGrand, Anita Edwards, Mbali Mohlamonyane, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 22, 2012
Rates and predictors of failure of first-line antiretroviral therapy and switch to second-line ART in South AfricaMatthew P Fox, Gilles Van Cutsem, Janet Giddy, et al.
AIDS (London, England)|May 11, 2013
Zidovudine impairs immunological recovery on first-line antiretroviral therapy: collaborative analysis of cohort studies in southern AfricaGilles Wandeler, Thomas Gsponer, Lloyd Mulenga, et al.
Annals of Internal Medicine|July 22, 2009
When to start antiretroviral therapy in resource-limited settingsRochelle P Walensky, Lindsey L Wolf, Robin Wood, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 5, 2021
Factors Associated With and Characteristic of HIV/Tuberculosis Co-Infection: A Retrospective Analysis of SECOND-LINE Clinical Trial ParticipantsRebecca T Henry, Awachana Jiamsakul, Matthew Law, et al.
AIDS (London, England)|July 1, 2014
Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in AfricaMaya L Petersen, Linh Tran, Elvin H Geng, et al.
The Pediatric Infectious Disease Journal|January 1, 2014
Virologic response in children treated with abacavir-compared with stavudine-based antiretroviral treatment: a South African multi-cohort analysisKarl-Günter Technau, Michael Schomaker, Louise Kuhn, et al.
BMJ Open|August 28, 2020
Novel approach to estimate tuberculosis transmission in primary care clinics in sub-Saharan Africa: protocol of a prospective studyKathrin Zürcher, Carl Morrow, Julien Riou, et al.
Pageof 37